⌘K

Login Start Free

Home/Filings/4/0001213900-19-013085

4//SEC Filing

Sank Leonard 4

Accession 0001213900-19-013085

CIK 0001176309other

View on SEC.gov Company Profile

Filed

Jul 17, 8:00 PM ET

Accepted

Jul 18, 1:31 PM ET

Size

10.8 KB

Accession

0001213900-19-013085

Insider Transaction Report

Form 4

Period: 2019-07-16

ORAMED PHARMACEUTICALS INC.ORMP

Director

Transactions

Purchase
Common Stock
2019-07-16$3.47/sh+20,000$69,316→ 315,482 total
Purchase
Common Stock
2019-07-18$3.85/sh+4,497$17,336→ 349,999 total
Purchase
Common Stock
2019-07-17$3.58/sh+20,000$71,562→ 335,482 total
Purchase
Common Stock
2019-07-17$3.74/sh+10,020$37,497→ 345,502 total

Holdings

Common Stock
(indirect: By Spouse)
78,125
Common Stock
(indirect: By Trust)
138,889

Footnotes (2)

[F1]Mr. Sank disclaims beneficial ownership of these shares.
[F2]These shares consist of shares of common stock owned by a company wholly owned by a trust of which Mr. Sank is a trustee. Mr. Sank disclaims beneficial ownership of these shares.

Documents

1 file

4
ownership.xmlPrimary

Issuer

ORAMED PHARMACEUTICALS INC.

CIK 0001176309

Entity typeother

Related Parties

1

filerCIK 0001416089

Filing Metadata

Form type: 4
Filed: Jul 17, 8:00 PM ET
Accepted: Jul 18, 1:31 PM ET
Size: 10.8 KB

View on SEC.gov